Resultado de búsqueda
Hace 1 día · Every day, our more than 130,000 employees globally are building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.
8 de may. de 2024 · Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision. Learn about Johnson & Johnson's extensive portfolio of healthcare products. Find solutions to meet your medical and wellness needs.
Hace 3 días · NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) announced today it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage biotechnology company advancing a pipeline of immunology and oncology therapeutics, to acquire from Numab's shareholders its wholly-owned subsidiary for the global rights to a novel, investigational first-in-class bispecific ...
6 de may. de 2024 · Todas las noticias sobre Johnson & Johnson publicadas en EL PAÍS. Información, novedades y última hora sobre Johnson & Johnson.
Hace 1 día · Redacción. 18/09/2023 · 09:14. Johnson & Johnson ha desvelado su nueva identidad visual de marca, con la que la compañía da comienzo a una nueva etapa estratégica que refleja su enfoque en la innovación en el terreno de la atención médica y el cuidado de la salud.
8 de may. de 2024 · For more than half a century, NASA’s Lyndon B. Johnson Space Center in Houston has led our nation and the world on a continuing adventure of human exploration, discovery and achievement. The center has played a vital role in powering our country into the 21st century through technological innovations and scientific discoveries.
24 de may. de 2024 · Johnson & Johnson : Presentación de la compañía Johnson & Johnson, accionistas, dirección, descripción del negocio, calificaciones financieras, comunicados de prensa oficiales, detalles de contacto y códigos de la bolsa de valores | JNJ | US4781601046 | Nyse.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/NQKETKFUS5DIP3WXS4CXHUFFMM.jpg&q=+Johnson&ck=82DE72119A45CB0A9CB810C81883E2E4&idpp=rc&idpview=singleimage&form=rc2idp "Johnson2")
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/VXH6WURPWVFD5IL3JWNZIUIJAU.JPG&q=+Johnson&ck=5C1338D94AA3BD0E26DF9FADEDD5D160&idpp=rc&idpview=singleimage&form=rc2idp "Johnson3")
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/OYELPMKCJWZB3LJXOBJBSBZXAA.jpg&q=+Johnson&ck=0AB38443219C0AE75D053A4A49CCA31C&idpp=rc&idpview=singleimage&form=rc2idp "Johnson4")
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/PKEH544P7RAX5NA3WTTJVPZJSM.jpg&q=+Johnson&ck=C332F059D3828C98FE22C74B740621FE&idpp=rc&idpview=singleimage&form=rc2idp "Johnson5")
